In situ malignant melanoma on nevus spilus in an elderly patient.

Acta Dermatovenerol Alp Pannonica Adriat

Dermatology Unit Azienda Ospedaliera Santa Maria degli Angeli, Pordenone, Padua, Italy. Anatomical Pathology Unit Azienda Ospedaliera Santa Maria degli Angeli, Pordenone, Padua, Italy. Oncology Unit Azienda Ospedaliera Santa Maria degli Angeli, Pordenone, Padua, Italy. Dermatologist Ambulatoriale Azienda Sanitaria n. 6 Friuli Occidentale, Pordenone, Padua, Italy. Corresponding author:

Published: March 2014

Nevus spilus is the term usually given to a pigmented skin lesion, congenital or acquired, that may occur anywhere on the body, consisting of a large light tan patch with numerous superimposed darker scattered maculae or papulae that are flat or slightly raised. For a long time, nevus spilus was believed to be a benign lesion. However, in 1957 Perkinson reported a melanoma appearing on nevus spilus for the first time. Since then other reports about melanomas developing on nevus spilus have been published, sometimes with a fatal outcome. We describe the case of an 80-year-old male patient with a congenital nevus just above his left knee. The lesion had remained unchanged over time, but some months before his checkup the patient noticed a darker area in the lesion that had continued to enlarge. The lesion was removed and histological examination revealed an in situ malignant melanoma. Although nevus spilus is not normally considered a precursor of melanoma, the potentiality of malignant transformation requires regular monitoring, and careful checkups are recommended and justified.

Download full-text PDF

Source

Publication Analysis

Top Keywords

nevus spilus
24
situ malignant
8
malignant melanoma
8
melanoma nevus
8
nevus
7
spilus
6
lesion
5
melanoma
4
spilus elderly
4
elderly patient
4

Similar Publications

Overlapping large facial nevus spilus and nevus of Ota: A case report diagnosed with dermoscopy and reflectance confocal microscopy.

Photodiagnosis Photodyn Ther

October 2024

Department of Dermatology, Air Force Medical Center, PLA, No.30 Fucheng Road, Beijing 100142, PR China. Electronic address:

Article Synopsis
  • A 25-year-old woman presented with a large facial hyperpigmentation that began as a blue-brown patch at one month old and progressively enlarged, covering the entire right side of her face.
  • Diagnosis involved dermoscopic and confocal microscopy exams, revealing overlapping conditions of nevus spilus and nevus of Ota, with no signs of cancer.
  • Successful treatment was achieved with a Q-switched alexandrite laser, demonstrating the importance of advanced imaging techniques in diagnosing and managing rare facial pigmentation disorders.
View Article and Find Full Text PDF

Nevus Spilus, Partial Unilateral Lentiginosis, and Linear and Whorled Nevoid Hypermelanosis: A Comparison of Clinical Features, Course, and Treatment Response.

Acta Derm Venereol

August 2024

Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea; Department of Dermatology, Seoul National University Hospital, Seoul, Korea; Institute of Human-Environmental Interface Biology, Medical Research Center, Seoul National University, Seoul, Korea.

Skin diseases manifesting as agminated pigmented lesions have overlapping clinical manifestations. Therefore, accurate differentiation is challenging. The clinical characteristics, histopathological findings, and treatment response of patients diagnosed with partial unilateral lentiginosis, nevus spilus, or linear and whorled nevoid hypermelanosis were retrospectively analysed.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated a new dermal cooling system (DCS) for treating benign pigmented lesions in Asian patients, focusing on its effectiveness and side effects.
  • Patients received up to 10 sessions of DCS treatment, showing significant improvements in lesions at 2, 6, and 12 months after treatment.
  • The results indicated that DCS was effective and safe with only minor side effects, making it a promising option for this type of skin treatment.
View Article and Find Full Text PDF

Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib.

Pediatr Dermatol

September 2024

Division of General Pediatrics, Section of Pediatric Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Article Synopsis
  • Giant congenital melanocytic nevi (GCMN) can be visually impactful and have the potential to develop into melanoma.
  • Currently, there is no established drug treatment for GCMN.
  • A case study describes an 8-year-old girl with kaposiform lymphangiomatosis linked to an NRAS mutation, whose GCMN showed improvement after treatment with oral selumetinib.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!